ReviewInternal medicine journal2026
Inequities in inflammatory bowel disease care: a Tasmanian case study with proposed solutions.
Review in Internal medicine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
There is well-recognised inequity of care for people treated with inflammatory bowel disease (IBD) between metropolitan and regional areas. We aim to describe these barriers to care using Tasmania as a case example and to suggest solutions for addressing these barriers that can be used in Tasmania and beyond. Tasmania has some of the highest rates of IBD in the world, with high rates of advanced therapy use reflecting a more complex population. The landscape of IBD care in Tasmania is marked by diverse challenges, some of which are unique to the state and others shared across regional Australia, all of which we appreciate negatively affects IBD outcomes in Tasmania. We formed a multidisciplinary working group from all three health services in Tasmania and identified keys issues facing Tasmanian's with IBD. The issues identified and proposed solutions were guided by Australian IBD reports and care standards, major society guidelines and our experience within the health service. The key barriers we describe include the underserviced IBD workforce, lack of multidisciplinary care, the isolation of the North West, inadequate expertise in certain areas and the absence of research and administrative infrastructure. We have developed a set of solutions designed to provide an actionable framework for improving care for Tasmanians living with IBD. These solutions encompass the development of multidisciplinary care in a regional setting, enhancing the IBD workforce, developing support for remote areas, upgrading diagnostic output, creating statewide research databases and investing in local training pathways. This action plan may serve as a model for other regional settings to deliver more equitable care in Australia and beyond.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.